Impact of HIV infection on baseline characteristics and survival of women with breast cancer

• Type: Article in International Scientific Journal
• Date: 2021

Authors

Brandão, M (Author) Other; Bruzzone, M (Author) Other; Franzoi, MA (Author) Other; De Angelis, C (Author) Other; Eiger, D (Author) Other; Caparica, R (Author) Other; Piccart Gebhart, M (Author) Other; Buisseret, L (Author) Other; Ceppi, M (Author) Other; Dauby, N (Author) Other; Carrilho, C (Author) Other; Lunet N (Author) FMUP; de Azambuja, E (Author) Other; Lambertini, M (Author) Other

Journal

Title: AIDS

Vol. 35

Pages: 605-618

ISSN: 0269-9370

Publisher: Wolters Kluwer Health

Indexing

Scopus - 10 Citations

Other information

Authenticus ID: P-00T-KZV

DOI: 10.1097/qad.0000000000002810

Abstract (EN): BACKGROUND: As women living with HIV (WLWH) become older, their risk of developing breast cancer increases. Nonetheless, literature is conflicting regarding tumor stage, distribution of subtypes and overall survival among WLWH vs. HIV-negative women with breast cancer. We assessed differences in clinicopathological characteristics and overall survival between these two groups. METHODS: Systematic review and meta-analysis using MEDLINE, Scopus, ISI Web of Knowledge, LILACS, SciELO and conference abstracts up to 1 January 2020. Cross-sectional/cohort studies comparing baseline characteristics (stage and/or subtypes) and/or overall survival of WLWH vs. HIV-negative women with breast cancer were included. We performed random-effects meta-analyses to estimate summary statistics and subgroup analyses according to region of the world. RESULTS: Eighteen studies [4 from North America, 14 from sub-Saharan Africa (SSA)] were included, with 3174 WLWH and 2¿394¿598 HIV-negative women. WLWH from North America and SSA were more likely to present with stage III/IV disease compared with HIV-negative women - pooled odds ratio (pOR) 1.76 [95% confidence interval (CI):1.58-1.95] and pOR 1.23 (95% CI: 1.06-1.42), respectively. WLWH from SSA were also less likely to have estrogen receptor-positive/HER2-negative tumors (pOR 0.81; 95% CI: 0.66-0.99). After adjustment, WLWH had worse overall survival compared with HIV-negative women, both in North America [pooled adjusted hazard ratio (aHR) 2.45; 95% CI: 1.11-5.41] and SSA (aHR 1.43; 95% CI: 1.06-1.92). CONCLUSION: Compared with HIV-negative women, WLWH are diagnosed with breast cancer at a more advanced stage and have a worse overall survival. These results should raise awareness regarding the detection and survival gap among WLWH with breast cancer and further studies are needed to decipher the reasons behind these disparities. Copyright

Language: English

Type (Professor's evaluation): Scientific